BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Immunotherapy
- Melanoma
- Metagenome
- Microbiome
- Non -Small Cell Lung Cancer
- Type
- Observational
- Design
- Observational Model: Case-OnlyTime Perspective: Cross-Sectional
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04136470
- Collaborators
- National Center for Research and Development, Poland
- Investigators
- Principal Investigator: Michal Warchol, PhD Ardigen